Our study including these advantages is consistent with a number of studies showing T cell death at doses much lower than those given here,7,36,37,38 including a study of patient-matched biopsies finding ∼90% decreases in infiltrating CD8+ T cells following radiation of cervical cancer at doses of 20–30 Gy.39 The gene discussed is CD8A; the disease is cervical carcinoma.